vs
STANDARD BIOTOOLS INC.（LAB）与Virginia National Bankshares Corp（VABK）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Virginia National Bankshares Corp的1.3倍（$19.6M vs $15.0M），Virginia National Bankshares Corp净利率更高（39.7% vs -177.4%，领先217.1%），Virginia National Bankshares Corp同比增速更快（3.6% vs -11.5%），Virginia National Bankshares Corp自由现金流更多（$20.8M vs $-23.1M），过去两年Virginia National Bankshares Corp的营收复合增速更高（7.0% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
联合银行股份有限公司是一家银行控股公司，双总部分别设于西弗吉尼亚州查尔斯顿与弗吉尼亚州费尔法克斯，业务覆盖美国多个州及华盛顿哥伦比亚特区。它是联合银行的母公司，联合银行在八个州拥有近250个网点，旗下还拥有乔治梅森抵押贷款、联合经纪等子公司。
LAB vs VABK — 直观对比
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $15.0M |
| 净利润 | $-34.7M | $6.0M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 50.5% |
| 净利率 | -177.4% | 39.7% |
| 营收同比 | -11.5% | 3.6% |
| 净利润同比 | -28.8% | 30.6% |
| 每股收益（稀释后） | $-0.09 | $1.10 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $15.0M | ||
| Q3 25 | $19.6M | $14.4M | ||
| Q2 25 | $21.8M | $14.1M | ||
| Q1 25 | $40.8M | $14.1M | ||
| Q4 24 | — | $14.5M | ||
| Q3 24 | $22.1M | $13.5M | ||
| Q2 24 | $22.5M | $12.9M | ||
| Q1 24 | $45.5M | $13.1M |
| Q4 25 | — | $6.0M | ||
| Q3 25 | $-34.7M | $4.6M | ||
| Q2 25 | $-33.5M | $4.2M | ||
| Q1 25 | $-26.0M | $4.5M | ||
| Q4 24 | — | $4.6M | ||
| Q3 24 | $-26.9M | $4.6M | ||
| Q2 24 | $-45.7M | $4.2M | ||
| Q1 24 | $-32.2M | $3.6M |
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
| Q4 25 | — | 50.5% | ||
| Q3 25 | -168.5% | 39.4% | ||
| Q2 25 | -118.1% | 38.4% | ||
| Q1 25 | -80.8% | 38.4% | ||
| Q4 24 | — | 40.3% | ||
| Q3 24 | -120.9% | 41.9% | ||
| Q2 24 | -134.5% | 39.5% | ||
| Q1 24 | -132.2% | 32.9% |
| Q4 25 | — | 39.7% | ||
| Q3 25 | -177.4% | 31.7% | ||
| Q2 25 | -153.7% | 30.0% | ||
| Q1 25 | -63.8% | 31.9% | ||
| Q4 24 | — | 31.4% | ||
| Q3 24 | -122.0% | 34.1% | ||
| Q2 24 | -203.3% | 32.3% | ||
| Q1 24 | -70.6% | 27.8% |
| Q4 25 | — | $1.10 | ||
| Q3 25 | $-0.09 | $0.84 | ||
| Q2 25 | $-0.09 | $0.78 | ||
| Q1 25 | $-0.07 | $0.83 | ||
| Q4 24 | — | $0.85 | ||
| Q3 24 | $-0.07 | $0.85 | ||
| Q2 24 | $-0.12 | $0.77 | ||
| Q1 24 | $-0.27 | $0.68 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $184.2M |
| 总资产 | $539.6M | $1.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | — | — | ||
| Q3 25 | $129.4M | — | ||
| Q2 25 | $158.6M | — | ||
| Q1 25 | $150.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $210.6M | — | ||
| Q2 24 | $269.8M | — | ||
| Q1 24 | $287.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
| Q4 25 | — | $184.2M | ||
| Q3 25 | $399.7M | $177.4M | ||
| Q2 25 | $424.5M | $170.8M | ||
| Q1 25 | $454.6M | $166.8M | ||
| Q4 24 | — | $160.3M | ||
| Q3 24 | $489.3M | $165.9M | ||
| Q2 24 | $510.3M | $154.2M | ||
| Q1 24 | $577.3M | $152.6M |
| Q4 25 | — | $1.6B | ||
| Q3 25 | $539.6M | $1.6B | ||
| Q2 25 | $557.0M | $1.6B | ||
| Q1 25 | $579.6M | $1.6B | ||
| Q4 24 | — | $1.6B | ||
| Q3 24 | $681.5M | $1.6B | ||
| Q2 24 | $708.7M | $1.6B | ||
| Q1 24 | $777.7M | $1.6B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $21.3M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $20.8M |
| 自由现金流率自由现金流/营收 | -118.1% | 138.2% |
| 资本支出强度资本支出/营收 | 4.5% | 3.9% |
| 现金转化率经营现金流/净利润 | — | 3.58× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $35.2M |
8季度趋势，按日历期对齐
| Q4 25 | — | $21.3M | ||
| Q3 25 | $-22.2M | $6.0M | ||
| Q2 25 | $-20.7M | $6.7M | ||
| Q1 25 | $-30.3M | $2.1M | ||
| Q4 24 | — | $15.3M | ||
| Q3 24 | $-27.9M | $15.2M | ||
| Q2 24 | $-39.0M | $-6.4M | ||
| Q1 24 | $-62.5M | $3.2M |
| Q4 25 | — | $20.8M | ||
| Q3 25 | $-23.1M | $5.9M | ||
| Q2 25 | $-22.6M | $6.7M | ||
| Q1 25 | $-35.3M | $1.8M | ||
| Q4 24 | — | $14.6M | ||
| Q3 24 | $-30.1M | $15.1M | ||
| Q2 24 | $-41.0M | $-6.8M | ||
| Q1 24 | $-63.3M | $3.1M |
| Q4 25 | — | 138.2% | ||
| Q3 25 | -118.1% | 41.0% | ||
| Q2 25 | -103.6% | 47.6% | ||
| Q1 25 | -86.6% | 13.0% | ||
| Q4 24 | — | 100.4% | ||
| Q3 24 | -136.4% | 111.7% | ||
| Q2 24 | -182.2% | -53.0% | ||
| Q1 24 | -138.9% | 23.9% |
| Q4 25 | — | 3.9% | ||
| Q3 25 | 4.5% | 0.5% | ||
| Q2 25 | 8.7% | 0.2% | ||
| Q1 25 | 12.4% | 1.8% | ||
| Q4 24 | — | 5.1% | ||
| Q3 24 | 10.2% | 0.9% | ||
| Q2 24 | 8.6% | 3.1% | ||
| Q1 24 | 1.7% | 0.2% |
| Q4 25 | — | 3.58× | ||
| Q3 25 | — | 1.31× | ||
| Q2 25 | — | 1.59× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 3.35× | ||
| Q3 24 | — | 3.30× | ||
| Q2 24 | — | -1.54× | ||
| Q1 24 | — | 0.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
VABK
暂无分部数据
